Chemical identity

Framycetin EP Impurity D / Neomycin D / Paromamine (3HCl)

CAS 18685-97-7 · C12H28Cl3N3O7

01Identity

Identifiers and names for this exact compound. Empty fields are left unassigned.

Lazychem IDLC-15891
PubChem CID92135131
NameFramycetin EP Impurity D / Neomycin D / Paromamine (3HCl)
CAS RN18685-97-7
Molecular formulaC12H28Cl3N3O7
Molecular weight432.73 g/mol
IUPAC name4-O-(2-Amino-2-deoxy-a-D-glucopyranosyl)-2-deoxy-D-streptamine trihydrochloride
InChIKeyCBBUYCLHSMNAGW-MHFNDSQWSA-N

02Structure identifiers

2D structure: Framycetin EP Impurity D / Neomycin D / Paromamine (3HCl), CAS 18685-97-7
Structure of Framycetin EP Impurity D / Neomycin D / Paromamine (3HCl) (CAS 18685-97-7). LazyChem record. Source identity: PubChem CID 92135131. Confirm the identifiers before analytical use.Download structure image

Structure facts for this exact identity.

Molecular formulaC12H28Cl3N3O7
InChIKeyCBBUYCLHSMNAGW-MHFNDSQWSA-N
Ring count2
Defined stereocentres10
Unassigned stereocentres0
SMILESC1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O)O)N.Cl.Cl.Cl
InChIInChI=1S/C12H25N3O7.3ClH/c13-3-1-4(14)11(10(20)7(3)17)22-12-6(15)9(19)8(18)5(2-16)21-12;;;/h3-12,16-20H,1-2,13-15H2;3*1H/t3-,4+,5-,6-,7+,8-,9-,10-,11-,12-;;;/m1.../s1

03Stereochemistry

The published structure contains 10 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.

Defined stereocentres102D structure
Unassigned stereocentres02D structure
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 1,024Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04India status for this compound

These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.

NDPS / RCSNOT FOUND IN REVIEWED ENTRIESCAS 18685-97-7 was not found in the reviewed exact-identity entries. Generic, class, analogue, salt and isomer provisions were not evaluated.
SCOMETNOT FOUND IN REVIEWED CAS ENTRIESCAS 18685-97-7 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated.

05Names and relationships

Associated parent compound

Framycetin

View API and impurity family

Other names

  • Framycetin EP Impurity D
  • Neomycin D
  • Paromamine (3HCl)
  • (2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-2-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol
  • Paromamine trihydrochloride
  • (2R,3S,4R,5R,6S)-5-Amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-2-(hydroxymethyl)oxane-3,4-diol
  • trihydrochloride
  • Streptamine, 4-O-(2-amino-2-deoxy-a-D-glucopyranosyl)-2-deoxy-,trihydrochloride

06Documented history

Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.

No dated history available

No verified discovery, first report, occurrence, use or issue event is currently available for this identity.

07Sources